Basal Insulin Case 2

CE / CME

The Role of Basal Insulin in the Modern Era of Diabetes Management: Interactive Case Challenge 2

ABIM MOC: maximum of 0.75 Medical Knowledge MOC point

Physician Assistants/Physician Associates: 0.75 AAPA Category 1 CME credit

Nurses: 0.75 Nursing contact hour

Physicians: maximum of 0.75 AMA PRA Category 1 Credit

Released: October 26, 2023

Expiration: October 25, 2024

Activity

Progress
1 2
Course Completed

Presurvey 

A patient with a history of type 2 diabetes is receiving metformin 1000 mg twice daily, dulaglutide 4.5 mg weekly, empagliflozin 25 mg daily, and insulin degludec 20 units daily. The patient’s most recent A1C is 8.5%, and he reports a fasting glucose average of 180 mg/dL with occasional hypoglycemic symptoms in the afternoon due to delayed meals. Which of the following is the best next step for this patient?